Content deleted Content added
combined repeated citations |
removed no longer needed PBB controls and templates; consistent citation formatting; removed further reading citations not specific to this gene |
||
Line 1:
{{Infobox_gene}}
'''Telomerase-binding protein EST1A''' is an [[enzyme]] that in humans is encoded by the ''SMG6'' [[gene]] on [[Chromosome 17 (human)|chromosome 17]].<ref name="pmid12676087">{{cite journal | vauthors = Reichenbach P,
== Structure ==
Line 8:
=== Protein ===
SMG6 is one of three human [[homologs]] for Est1p found in [[Saccharomyces cerevisiae]]. It contains a PIN domain, which is characteristic of proteins with [[ribonuclease]] activity.<ref>{{
== Function ==
SMG6 is broadly expressed in all human tissues. It has dual functions in [[telomere]] maintenance and [[RNA]] surveillance pathways. SMG6 binds single-stranded telomere DNA and cooperates with [[telomerase]] reverse transcriptase to lengthen telomeres.<ref name="pmid12699629" /> Overexpression of SMG6 induces anaphase bridges due to chromosome-end fusions and, thus, affects telomere capping, which may directly induce an apoptotic response.<ref name="pmid10037601">{{cite journal |
== Clinical significance ==
Line 19:
=== Clinical marker ===
A multi-locus genetic risk score study based on a combination of 27 loci, including the SMG6 gene, identified individuals at increased risk for both incident and recurrent coronary artery disease events, as well as an enhanced clinical benefit from statin therapy. The study was based on a community cohort study (the Malmo Diet and Cancer study) and four additional randomized controlled trials of primary prevention cohorts (JUPITER and ASCOT) and secondary prevention cohorts (CARE and PROVE IT-TIMI 22).<ref name=":0">{{cite journal | vauthors = Mega JL, Stitziel NO, Smith JG, Chasman DI, Caulfield MJ, Devlin JJ, Nordio F, Hyde CL, Cannon CP, Sacks FM, Poulter NR, Sever PS, Ridker PM, Braunwald E, Melander O, Kathiresan S, Sabatine MS | title = Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials | journal = Lancet | volume = 385 | issue = 9984 | pages = 2264–71 | date = June 2015 | pmid = 25748612 | doi = 10.1016/S0140-6736(14)61730-X }}</ref>
{{clear}}
== References ==▼
{{reflist|33em}}
== Further reading ==▼
▲==References==
{{
* {{cite journal
* {{cite journal
* {{cite journal
* {{cite journal
* {{cite journal
* {{cite journal
* {{cite journal
* {{cite journal
* {{cite journal
* {{cite journal
{{refend}}▼
▲==Further reading==
▲*{{cite journal |vauthors=Nakajima D, Okazaki N, Yamakawa H, etal |title=Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones. |journal=DNA Res. |volume=9 |issue= 3 |pages= 99–106 |year= 2003 |pmid= 12168954 |doi=10.1093/dnares/9.3.99 }}
▲*{{cite journal |vauthors=Nagase T, Ishikawa K, Suyama M, etal |title=Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. |journal=DNA Res. |volume=5 |issue= 5 |pages= 277–86 |year= 1999 |pmid= 9872452 |doi=10.1093/dnares/5.5.277 }}
▲*{{cite journal |vauthors=Hoff C, Seranski P, Mollenhauer J, etal |title=Physical and transcriptional mapping of the 17p13.3 region that is frequently deleted in human cancer. |journal=Genomics |volume=70 |issue= 1 |pages= 26–33 |year= 2001 |pmid= 11087658 |doi= 10.1006/geno.2000.6353 }}
▲*{{cite journal | vauthors=Chiu SY, Serin G, Ohara O, Maquat LE |title=Characterization of human Smg5/7a: a protein with similarities to Caenorhabditis elegans SMG5 and SMG7 that functions in the dephosphorylation of Upf1. |journal=RNA |volume=9 |issue= 1 |pages= 77–87 |year= 2003 |pmid= 12554878 |doi=10.1261/rna.2137903 | pmc=1370372 }}
▲*{{cite journal |vauthors=Ohnishi T, Yamashita A, Kashima I, etal |title=Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7. |journal=Mol. Cell |volume=12 |issue= 5 |pages= 1187–200 |year= 2004 |pmid= 14636577 |doi=10.1016/S1097-2765(03)00443-X }}
▲*{{cite journal |vauthors=Fukuhara N, Ebert J, Unterholzner L, etal |title=SMG7 is a 14-3-3-like adaptor in the nonsense-mediated mRNA decay pathway. |journal=Mol. Cell |volume=17 |issue= 4 |pages= 537–47 |year= 2005 |pmid= 15721257 |doi= 10.1016/j.molcel.2005.01.010 }}
▲*{{cite journal | vauthors=Azzalin CM, Lingner J |title=The human RNA surveillance factor UPF1 is required for S phase progression and genome stability. |journal=Curr. Biol. |volume=16 |issue= 4 |pages= 433–9 |year= 2006 |pmid= 16488880 |doi= 10.1016/j.cub.2006.01.018 }}
▲*{{cite journal |vauthors=Takeshita D, Zenno S, Lee WC, etal |title=Crystallization and preliminary X-ray analysis of the PIN domain of human EST1A. |journal=Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. |volume=62 |issue= Pt 7 |pages= 656–8 |year= 2006 |pmid= 16820686 |doi= 10.1107/S1744309106020057 | pmc=2242961 }}
▲*{{cite journal | vauthors=Glavan F, Behm-Ansmant I, Izaurralde E, Conti E |title=Structures of the PIN domains of SMG6 and SMG5 reveal a nuclease within the mRNA surveillance complex. |journal=EMBO J. |volume=25 |issue= 21 |pages= 5117–25 |year= 2007 |pmid= 17053788 |doi= 10.1038/sj.emboj.7601377 | pmc=1630413 }}
▲*{{cite journal |vauthors=Takeshita D, Zenno S, Lee WC, etal |title=Crystal structure of the PIN domain of human telomerase-associated protein EST1A. |journal=Proteins |volume=68 |issue= 4 |pages= 980–9 |year= 2007 |pmid= 17557331 |doi= 10.1002/prot.21351 }}
▲{{refend}}
{{PDB Gallery|geneid=23293}}
{{gene-17-stub}}
|